Quantitative analysis for BrainsWay Ltd. (BWAY) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (67.0) (grade B). 29 signals analyzed (24 differentiated alt-data).
BWAY stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $16.04 | $15.61 | $15.88 |
| 2026-05-11 | $16.91 | $16.33 | $16.73 |
| 2026-05-21 | $15.32 | $14.95 | $15.08 |
| 2026-06-03 | $14.23 | $13.78 | $14.04 |
| 2026-06-15 | $14.79 | $14.15 | $14.33 |
| 2026-06-26 | $14.94 | $14.33 | $14.48 |
| 2026-07-09 | $15.22 | $14.79 | $15.09 |
| 2026-07-21 | $16.82 | $15.90 | $16.15 |
| 2026-07-31 | $15.72 | $14.82 | $15.23 |
| 2026-08-12 | $17.40 | $14.81 | $16.60 |
| 2026-08-24 | $14.53 | $14.10 | $14.19 |
| 2026-09-03 | $14.68 | $14.30 | $14.51 |
How BrainsWay Ltd. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $598M | 50.0 |
| ANL | Adlai Nortye Ltd. | $603M | 41.0 |
| TLRY | Tilray Brands, Inc. | $647M | — |
| PROK | ProKidney Corp. | $545M | — |
View all Health Care stocks by valuation and signals →
BrainsWay Ltd. (BWAY) scores Buy (67.0), and the composite conceals a 45-point disagreement between its dimensions. It is strongest on analyst consensus at 82 and valuation at 72, and weakest on ML forecast at 37. A stock can carry analyst consensus that high while ML forecast sits at 37; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 82 |
| valuation | 72 |
| technicals | 64 |
| ML forecast | 37 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on BrainsWay Ltd. (BWAY): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/BWAY"><img src="https://stoquant.com/badge/BWAY.svg" alt="BrainsWay Ltd. (BWAY) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.